Surgical Treatment for Lung Cancer
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Pulmonology".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 17
Special Issue Editors
Interests: lung cancer surgery; minimally invasive surgery; enhanced recovery after surgery; quality improvement; lung transplantation
Interests: mediastinal tumors; lung cancer; lung transplantation; minimally invasive surgery; multimodality treatment
Special Issue Information
Dear Colleagues,
Despite significant progress, lung cancer remains a leading cause of cancer-related mortality worldwide. This Special Issue will explore advancements and ongoing challenges in the surgical treatment of lung cancer. Our aim is to compile high-quality research that addresses current limitations and innovates surgical practices to improve patient outcomes.
The Special Issue seeks to cover a broad spectrum of topics, including, but not limited to, surgical techniques, perioperative care, and multimodality treatment. We will discuss minimally invasive surgery (video-assisted and robotic-assisted thoracic surgery), the role, limitations, and technical advancements of segmental resections, and surgical treatment in advanced lung cancer. Additionally, we will focus on the role of Enhanced Recovery After Surgery (ERAS) protocols in preventing postoperative complications and the integration of immunotherapy with surgery for improvement of lung cancer treatment results. We encourage submissions that provide insights into overcoming core problems, such as the limitations of existing surgical methods and the effective combination of multimodal therapies. By bringing together leading experts and the latest research, this Special Issue aims to advance the standards of surgical care in lung cancer treatment and foster collaborations that lead to transformative clinical practices.
We invite researchers and clinicians to contribute original research articles and reviews that reflect the current state of the art and pave the way for future innovations in lung cancer surgery.
Dr. Piotr Gabryel
Dr. Cezary Piwkowski
Dr. Marek Ochman
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung cancer
- surgery
- minimally invasive surgery
- immunotherapy
- enhanced recovery after surgery
- segmentectomy
